171 related articles for article (PubMed ID: 6815044)
1. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
Rector WG; Hossack KF
J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
[TBL] [Abstract][Full Text] [Related]
4. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K
Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
[TBL] [Abstract][Full Text] [Related]
6. Portal hemodynamics during nitroglycerin administration in cirrhotic patients.
Garcia-Tsao G; Groszmann RJ
Hepatology; 1987; 7(5):805-9. PubMed ID: 3115881
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
Westaby D; Gimson A; Hayes PC; Williams R
Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
[TBL] [Abstract][Full Text] [Related]
9. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T
Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
[TBL] [Abstract][Full Text] [Related]
10. Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses.
Rector WG; Hossack KF; Ready JB
J Hepatol; 1990 May; 10(3):375-80. PubMed ID: 2114438
[TBL] [Abstract][Full Text] [Related]
11. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
Moreau R; Cailmail S; Lebrec D
Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029
[TBL] [Abstract][Full Text] [Related]
12. The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.
Kroeger RJ; Groszmann RJ
Hepatology; 1985; 5(3):425-30. PubMed ID: 3922868
[TBL] [Abstract][Full Text] [Related]
13. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ
J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437
[TBL] [Abstract][Full Text] [Related]
14. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
15. Effect of intraportal nitroglycerin on portosystemic hemodynamics in patients with cirrhosis: comparison with i.v. route.
Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
J Clin Gastroenterol; 1991 Aug; 13(4):424-31. PubMed ID: 1918848
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
17. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
[TBL] [Abstract][Full Text] [Related]
18. Effects of vasopressin on portal hemodynamics in patients with portal hypertension.
Ohnishi K; Saito M; Nakayama T; Hatano H; Okuda K
Am J Gastroenterol; 1987 Feb; 82(2):135-8. PubMed ID: 2949601
[TBL] [Abstract][Full Text] [Related]
19. Effects of vaso-active agents on hepatic function and blood gases in patients with cirrhosis: a study of vasopressin and nitroglycerin.
Iwao T; Toyonaga A; Sumino M; Takagi K; Oho K; Ohkubo K; Inoue R; Tanikawa K
J Gastroenterol Hepatol; 1992; 7(2):148-53. PubMed ID: 1571496
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological vs. mechanical reduction in portal pressure: a comparative study.
Groszmann RJ; Blei AT; Storer EH; Conn HO
Surgery; 1978 Nov; 84(5):679-85. PubMed ID: 715683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]